Treehub by AI Health Fund Launches to Identify Next-Generation Academic and Scientific Founders
Treehub, a newly launched Stanford-adjacent residency backed by the AI Health Fund, is positioning itself as a transformative force in healthcare innovation by identifying and supporting early-stage founders emerging from academia and scientific research. Located in Los Altos, just minutes from Stanford University, the program is designed to address a long-standing gap in the innovation pipeline: the critical stage between breakthrough discovery and the formation of a venture-backed company.
While Silicon Valley has long celebrated the myth of startups born in garages, Treehub challenges that narrative. According to its leadership, the next generation of groundbreaking healthcare companies is far more likely to originate in research labs, where scientists and clinicians are developing cutting-edge solutions but often lack access to venture capital, mentorship, and commercialization pathways. By focusing on this overlooked stage, Treehub aims to ensure that promising ideas do not stall before reaching real-world impact.
The initiative is supported by prominent figures in technology and healthcare, including billionaire investor Tim Draper and Anne Wojcicki, founder of 23andMe. Their involvement underscores the program’s ambition to bridge the worlds of scientific discovery and entrepreneurial execution, particularly in the rapidly evolving field of artificial intelligence in healthcare.
Mary Minno, Founding Partner of Treehub, emphasized the importance of rethinking how innovation is funded and nurtured. She noted that many of the most promising healthcare breakthroughs originate from scientists who have spent years developing expertise but have historically lacked early-stage support from venture investors. Treehub seeks to change this by building a founder-first ecosystem tailored specifically to academic innovators rather than forcing them into traditional venture models that may not suit their needs.
At the core of Treehub’s approach is its venture arm, AI Health Fund, which commits capital at the earliest possible stage—often before a company is formally established. This early investment model allows founders to focus on refining their ideas and building viable solutions without the immediate pressure of securing funding. In addition to capital, participants gain access to a highly curated network of operators, healthcare stakeholders, investors, and experienced founders who have successfully built and exited startups.
Treehub differentiates itself by combining elements of a venture studio, incubator, and venture fund into a single integrated platform. This hybrid model enables founders to receive hands-on guidance, participate in structured programming, and leverage exclusive datasets and medical insights that are typically inaccessible to traditional investors. The goal is to accelerate the transition from academic research to scalable healthcare solutions, particularly in areas where AI and scientific innovation intersect.
The leadership team behind Treehub brings together expertise across technology, medicine, and finance. Mary Minno previously worked as a venture-backed founder and held a product management role at Google. She is joined by Dr. Roxana Daneshjou, a physician-scientist and Assistant Professor at Stanford Medicine specializing in biomedical data science and dermatology. Dr. Alexander Ioannidis, a Stanford professor and founder of Galatea Bio, contributes deep expertise in genetics and computational biology. Derek Minno, President of Point Capital, adds decades of experience managing large-scale investment portfolios.
The program also benefits from the guidance of Esther Wojcicki, a respected educator and influential figure in Silicon Valley, who serves as a Founding Advisor. Her philosophy, encapsulated in the TRICK framework—Trust, Respect, Independence, Collaboration, and Kindness—plays a foundational role in shaping Treehub’s culture and approach to founder development. Anne Wojcicki, serving as Operating Partner, brings firsthand experience in building a pioneering genomics company and scaling it into a global enterprise.
Treehub is built on the belief that healthcare innovation has not been limited by a lack of ideas, but rather by a misalignment of resources and investment priorities. Many traditional venture models prioritize incremental software solutions, while some of the most transformative opportunities lie in deeper scientific domains such as biology, genomics, and AI-driven discovery. By focusing on these areas, Treehub aims to unlock breakthroughs that can meaningfully improve patient outcomes and address systemic challenges in healthcare.
The organization has identified three key domains where the convergence of AI and science is expected to reshape the future of healthcare.
The first, Precision Outcomes, focuses on delivering personalized care tailored to individual patients. This includes advancements in genomic risk assessment, predictive diagnostics, and consumer-driven healthcare models that empower patients with more control over their treatment options.
The second domain, Care Efficiency, addresses the operational challenges that burden healthcare systems worldwide. By leveraging AI-powered tools such as ambient intelligence and automated workflows, Treehub-supported companies aim to reduce administrative overhead, streamline logistics, and allow healthcare professionals to focus more on patient care.
The third domain, Frontier Science, encompasses breakthrough technologies that have the potential to redefine medical capabilities. This includes innovations such as robotic surgery, digital twin simulations, and advanced computational models that can predict disease progression and treatment outcomes with unprecedented accuracy.
Anne Wojcicki highlighted the importance of providing timely support to scientists, noting that access to the right resources at the right moment can significantly accelerate the translation of research into real-world applications. Treehub’s model is designed to make this process more systematic and scalable, ensuring that high-potential ideas are not lost due to lack of early-stage backing.
Ultimately, Treehub represents a shift in how the healthcare innovation ecosystem approaches talent and ideas. By centering its efforts on academic founders and providing them with capital, mentorship, and infrastructure from the outset, the program seeks to create a new generation of companies capable of addressing some of the most pressing challenges in medicine today.
About Treehub
Treehub is a boutique residency program for scientist-founders in healthcare, backed by AI Health Fund. Situated just off Stanford’s campus and with partners from Stanford’s Biomedical Data Science faculty, Treehub runs cohorts of up to 10 companies four times per year. The inaugural cohort launches Stanford Spring Quarter 2026.
About AI Health Fund:
AI Health Fund is an investment vehicle purpose-built to identify and back early-stage founders emerging from academic ecosystems at the intersection of AI and medicine.
